SCHEMBL16843352

SCHEMBL16843352

C=Cc1ccc(-c2c(C(C)O)oc(=O)c3ccccc23)s1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ACHE P22303 3/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ CASP3 P42574 1/20 0.31
▸ SENP8 Q96LD8 1/20 0.31
▸ SENP7 Q9BQF6 1/20 0.31
▸ SENP6 Q9GZR1 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ ESR2 Q92731 2/20 0.30
▸ BCHE P06276 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16783503 0.90 KDM4E (0.38) ALDH1A1MEN1KMT2AGAASMN1; SMN2
SCHEMBL16783830 0.82 ACHE (0.32) ALDH1A1MEN1KMT2ASMN1; SMN2ACHE
SCHEMBL16783829 0.82 ACHE (0.32) ALDH1A1MEN1KMT2ASMN1; SMN2ACHE
SCHEMBL21337721 0.79 CYP1A2 (0.36) ALDH1A1SMN1; SMN2ACHE
SCHEMBL16806402 0.76 ALDH1A1 (0.43) ALDH1A1MEN1KMT2ANPSR1MAPT
SCHEMBL21337764 0.76 ALDH1A1 (0.34) ALDH1A1MEN1KMT2AMAPT
SCHEMBL16783653 0.75 MEN1 (0.31) ALDH1A1MEN1KMT2AGAASMN1; SMN2
SCHEMBL16783515 0.75 NPC1 (0.44) ALDH1A1MEN1KMT2AGAANPSR1
Hydrochloric Acid SCHEMBL16783779 0.75 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ANPSR1MAPT
SCHEMBL16783734 0.75 KDM4E (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015091685-A1 ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-25 — — WO disclosed
Send feedback